Overview

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
To monitor use in real practice including safety and efficacy of Champix tablets 0.5mg, 1mg medication for 12 weeks in smokers
Details
Lead Sponsor:
Pfizer
Treatments:
Varenicline